Are CYP1A1 polymorphisms associated with the risk of hepatocellular carcinoma?

  • Tao Yu Wan
  • Published 2012 in Molecular Biology Reports


I read with interest the recent meta-analysis by Yu et al. [1] and the comment on this article by Liu et al. [2]. Yu et al. [1] reported that neither Ile-Val nor MspI polymorphism was associated with hepatocellular carcinoma (HCC) risk, while two polymorphisms might play key roles in increasing susceptibility to smoking-related HCC. Regarding to this meta… (More)
DOI: 10.1007/s11033-012-2464-4


3 Figures and Tables

Slides referencing similar topics